Structures of HIV-1 gp120 envelope glycoproteins from laboratory-adapted and primary isolates.

[1]  D. Kerjaschki,et al.  The beta-chemokine receptor D6 is expressed by lymphatic endothelium and a subset of vascular tumors. , 2001, The American journal of pathology.

[2]  J. Sodroski,et al.  The Level of CD4 Expression Limits Infection of Primary Rhesus Monkey Macrophages by a T-Tropic Simian Immunodeficiency Virus and Macrophagetropic Human Immunodeficiency Viruses , 2000, Journal of Virology.

[3]  L. Stamatatos,et al.  V2 Loop Glycosylation of the Human Immunodeficiency Virus Type 1 SF162 Envelope Facilitates Interaction of This Protein with CD4 and CCR5 Receptors and Protects the Virus from Neutralization by Anti-V3 Loop and Anti-CD4 Binding Site Antibodies , 2000, Journal of Virology.

[4]  W A Hendrickson,et al.  Energetics of the HIV gp120-CD4 binding reaction. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[5]  D. Kabat,et al.  Critical role of enhanced CD4 affinity in laboratory adaptation of human immunodeficiency virus type 1. , 2000, AIDS research and human retroviruses.

[6]  J. Sodroski,et al.  Oligomeric Modeling and Electrostatic Analysis of the gp120 Envelope Glycoprotein of Human Immunodeficiency Virus , 2000, Journal of Virology.

[7]  B L Trus,et al.  Three-dimensional structure of poliovirus receptor bound to poliovirus. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Sodroski,et al.  Energetics of the HIV gp 120-CD 4 binding reaction , 2000 .

[9]  M. Bewley,et al.  Structural analysis of the mechanism of adenovirus binding to its human cellular receptor, CAR. , 1999, Science.

[10]  Jordi Bella,et al.  Structural studies of two rhinovirus serotypes complexed with fragments of their cellular receptor , 1999, The EMBO journal.

[11]  S. Coppens,et al.  Intrapatient variability of HIV type 1 group O ANT70 during a 10-year follow-up. , 1999, AIDS research and human retroviruses.

[12]  J. Sodroski,et al.  Determinants of Neutralization Resistance in the Envelope Glycoproteins of a Simian-Human Immunodeficiency Virus Passaged In Vivo , 1999, Journal of Virology.

[13]  Amanda M. Brown,et al.  Selection for Neutralization Resistance of the Simian/Human Immunodeficiency Virus SHIVSF33A Variant In Vivo by Virtue of Sequence Changes in the Extracellular Envelope Glycoprotein That Modify N-Linked Glycosylation , 1999, Journal of Virology.

[14]  Joseph Sodroski,et al.  Tyrosine Sulfation of the Amino Terminus of CCR5 Facilitates HIV-1 Entry , 1999, Cell.

[15]  J. Sodroski,et al.  Probability Analysis of Variational Crystallization and Its Application to gp120, The Exterior Envelope Glycoprotein of Type 1 Human Immunodeficiency Virus (HIV-1)* , 1999, The Journal of Biological Chemistry.

[16]  C. J. Lusty.  A gentle vapor-diffusion technique for cross-linking of protein crystals for cryocrystallography , 1999 .

[17]  P. D. Kwong,et al.  Use of cryoprotectants in combination with immiscible oils for flash cooling macromolecular crystals , 1999 .

[18]  Q. Sattentau,et al.  The neutralizing antibody response to HIV-1: viral evasion and escape from humoral immunity. , 1999, AIDS.

[19]  R J Read,et al.  Crystallography & NMR system: A new software suite for macromolecular structure determination. , 1998, Acta crystallographica. Section D, Biological crystallography.

[20]  C. Barbas,et al.  Determinants of Human Immunodeficiency Virus Type 1 Envelope Glycoprotein Activation by Soluble CD4 and Monoclonal Antibodies , 1998, Journal of Virology.

[21]  Ying Sun,et al.  A conserved HIV gp120 glycoprotein structure involved in chemokine receptor binding. , 1998, Science.

[22]  J. Sodroski,et al.  The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens. , 1998, Science.

[23]  J. Sodroski,et al.  Structure of an HIV gp120 envelope glycoprotein in complex with the CD4 receptor and a neutralizing human antibody , 1998, Nature.

[24]  Peter D. Kwong,et al.  The antigenic structure of the HIV gp120 envelope glycoprotein , 1998, Nature.

[25]  Q. Sattentau,et al.  Neutralization of Human Immunodeficiency Virus Type 1 by Antibody to gp120 Is Determined Primarily by Occupancy of Sites on the Virion Irrespective of Epitope Specificity , 1998, Journal of Virology.

[26]  S. Matsushita,et al.  The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism. , 1997, AIDS research and human retroviruses.

[27]  B. Chesebro,et al.  Selective employment of chemokine receptors as human immunodeficiency virus type 1 coreceptors determined by individual amino acids within the envelope V3 loop , 1997, Journal of virology.

[28]  W. Hendrickson,et al.  Dimeric association and segmental variability in the structure of human CD4 , 1997, Nature.

[29]  S. Harrison,et al.  Atomic structure of the ectodomain from HIV-1 gp41 , 1997, Nature.

[30]  B. Cullen,et al.  HIV‐1‐induced cell fusion is mediated by multiple regions within both the viral envelope and the CCR‐5 co‐receptor , 1997, The EMBO journal.

[31]  Deborah Fass,et al.  Core Structure of gp41 from the HIV Envelope Glycoprotein , 1997, Cell.

[32]  A. Trkola,et al.  Neutralization of the human immunodeficiency virus type 1 primary isolate JR-FL by human monoclonal antibodies correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex , 1997, Journal of virology.

[33]  K. Peden,et al.  CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1 , 1997, Journal of virology.

[34]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[35]  W. Hendrickson,et al.  Kinetic and structural analysis of mutant CD4 receptors that are defective in HIV gp120 binding. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Joseph Sodroski,et al.  CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5 , 1996, Nature.

[37]  A. Garzino-Demo,et al.  The V3 domain of the HIV–1 gp120 envelope glycoprotein is critical for chemokine–mediated blockade of infection , 1996, Nature Medicine.

[38]  C. Broder,et al.  CC CKR5: A RANTES, MIP-1α, MIP-1ॆ Receptor as a Fusion Cofactor for Macrophage-Tropic HIV-1 , 1996, Science.

[39]  Marc Parmentier,et al.  A Dual-Tropic Primary HIV-1 Isolate That Uses Fusin and the β-Chemokine Receptors CKR-5, CKR-3, and CKR-2b as Fusion Cofactors , 1996, Cell.

[40]  Ying Sun,et al.  The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates , 1996, Cell.

[41]  Virginia Litwin,et al.  HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5 , 1996, Nature.

[42]  Stephen C. Peiper,et al.  Identification of a major co-receptor for primary isolates of HIV-1 , 1996, Nature.

[43]  Paul E. Kennedy,et al.  HIV-1 Entry Cofactor: Functional cDNA Cloning of a Seven-Transmembrane, G Protein-Coupled Receptor , 1996, Science.

[44]  J. Hansen,et al.  Rapid selection for an N-linked oligosaccharide by monoclonal antibodies directed against the V3 loop of human immunodeficiency virus type 1. , 1996, The Journal of general virology.

[45]  Todd O. Yeates,et al.  Why protein crystals favour some space-groups over others , 1995, Nature Structural Biology.

[46]  Ying Sun,et al.  Replicative function and neutralization sensitivity of envelope glycoproteins from primary and T-cell line-passaged human immunodeficiency virus type 1 isolates , 1995, Journal of virology.

[47]  H. Schuitemaker,et al.  Adaptation to persistent growth in the H9 cell line renders a primary isolate of human immunodeficiency virus type 1 sensitive to neutralization by vaccine sera , 1995, Journal of virology.

[48]  A. Mosser,et al.  Distribution of drug resistance mutations in type 3 poliovirus identifies three regions involved in uncoating functions , 1994, Journal of virology.

[49]  J. Bibb,et al.  Interaction of poliovirus with its cell surface binding site. , 1994, Virology.

[50]  B. Chesebro,et al.  Differences in CD4 dependence for infectivity of laboratory-adapted and primary patient isolates of human immunodeficiency virus type 1 , 1994, Journal of virology.

[51]  C. Cheng‐Mayer,et al.  Functional role of the V1/V2 region of human immunodeficiency virus type 1 envelope glycoprotein gp120 in infection of primary macrophages and soluble CD4 neutralization , 1994, Journal of virology.

[52]  J. Navaza,et al.  AMoRe: an automated package for molecular replacement , 1994 .

[53]  W. Hendrickson,et al.  Structures of an HIV and MHC binding fragment from human CD4 as refined in two crystal lattices. , 1994, Structure.

[54]  B. Cullen,et al.  Identification of envelope V3 loop as the major determinant of CD4 neutralization sensitivity of HIV-1. , 1992, Science.

[55]  E. G. Shpaer,et al.  Human immunodeficiency virus type 1 envelope gene structure and diversity in vivo and after cocultivation in vitro , 1992, Journal of virology.

[56]  J. Moore,et al.  Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sensitive isolates , 1992, Journal of virology.

[57]  Axel T. Brunger,et al.  X-PLOR Version 3.1: A System for X-ray Crystallography and NMR , 1992 .

[58]  K. Sharp,et al.  Protein folding and association: Insights from the interfacial and thermodynamic properties of hydrocarbons , 1991, Proteins.

[59]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[60]  A. Fisher,et al.  Molecular characterization of biologically diverse envelope variants of human immunodeficiency virus type 1 derived from an individual , 1991, Journal of virology.

[61]  I. Chen,et al.  Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[62]  J. Kappes,et al.  Molecular characterization of human immunodeficiency virus type 1 cloned directly from uncultured human brain tissue: identification of replication-competent and -defective viral genomes , 1991, Journal of virology.

[63]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[64]  Peter D. Kwong,et al.  Crystal structure of an HIV-binding recombinant fragment of human CD4 , 1990, Nature.

[65]  Thomas P. J. Garrett,et al.  Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains , 1990, Nature.

[66]  David Looney,et al.  Biologically diverse molecular variants within a single HIV-1 isolate , 1988, Nature.

[67]  T. Copeland,et al.  Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene. , 1985, Science.

[68]  D. Filman,et al.  Three-dimensional structure of poliovirus at 2.9 A resolution. , 1985, Science.

[69]  John E. Johnson,et al.  Structure of a human common cold virus and functional relationship to other picornaviruses , 1985, Nature.

[70]  J. Sodroski,et al.  Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III. , 1985, Science.

[71]  M. Gonda,et al.  Characterization of envelope and core structural gene products of HTLV-III with sera from AIDS patients. , 1985, Science.

[72]  B. Haynes,et al.  Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS. , 1984, Science.

[73]  M. Greaves,et al.  The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus , 1984, Nature.

[74]  J. Chermann,et al.  Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). , 1983, Science.

[75]  M. Perutz,et al.  Regulation of oxygen affinity of hemoglobin: influence of structure of the globin on the heme iron. , 1979, Annual review of biochemistry.

[76]  W. Wooster,et al.  Crystal structure of , 2005 .